Market Closed -
London S.E.
11:35:06 2024-05-17 am EDT
|
5-day change
|
1st Jan Change
|
329
GBX
|
-1.02%
|
|
+0.37%
|
+2.29%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
30,229
|
29,703
|
30,045
|
-
|
-
|
Enterprise Value (EV)
1 |
40,097
|
38,217
|
37,859
|
37,117
|
36,515
|
P/E ratio
|
28.5
x
|
28.5
x
|
20.5
x
|
17.9
x
|
16.6
x
|
Yield
|
-
|
1.87%
|
1.87%
|
2.16%
|
2.36%
|
Capitalization / Revenue
|
2.78
x
|
2.63
x
|
2.62
x
|
2.52
x
|
2.41
x
|
EV / Revenue
|
3.69
x
|
3.38
x
|
3.31
x
|
3.11
x
|
2.93
x
|
EV / EBITDA
|
14.7
x
|
13.5
x
|
13.2
x
|
12.3
x
|
11.5
x
|
EV / FCF
|
22.8
x
|
20.5
x
|
25.6
x
|
21.8
x
|
19.9
x
|
FCF Yield
|
4.39%
|
4.88%
|
3.91%
|
4.58%
|
5.02%
|
Price to Book
|
1.85
x
|
1.79
x
|
1.76
x
|
1.66
x
|
1.57
x
|
Nbr of stocks (in thousands)
|
9,234,574
|
9,234,574
|
9,132,301
|
-
|
-
|
Reference price
2 |
3.274
|
3.216
|
3.290
|
3.290
|
3.290
|
Announcement Date
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,858
|
11,302
|
11,450
|
11,932
|
12,468
|
EBITDA
1 |
2,730
|
2,831
|
2,867
|
3,027
|
3,176
|
EBIT
1 |
1,825
|
2,549
|
2,586
|
2,727
|
2,886
|
Operating Margin
|
16.81%
|
22.55%
|
22.58%
|
22.85%
|
23.15%
|
Earnings before Tax (EBT)
1 |
1,618
|
1,628
|
2,015
|
2,345
|
2,524
|
Net income
1 |
1,060
|
1,049
|
1,461
|
1,686
|
1,815
|
Net margin
|
9.76%
|
9.28%
|
12.76%
|
14.13%
|
14.56%
|
EPS
2 |
0.1150
|
0.1130
|
0.1605
|
0.1843
|
0.1977
|
Free Cash Flow
1 |
1,759
|
1,866
|
1,480
|
1,700
|
1,833
|
FCF margin
|
16.2%
|
16.51%
|
12.92%
|
14.25%
|
14.7%
|
FCF Conversion (EBITDA)
|
64.43%
|
65.91%
|
51.6%
|
56.17%
|
57.72%
|
FCF Conversion (Net income)
|
165.94%
|
177.88%
|
101.24%
|
100.83%
|
100.97%
|
Dividend per Share
2 |
-
|
0.0600
|
0.0616
|
0.0712
|
0.0778
|
Announcement Date
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
---|
Net sales
1 |
2,627
|
-
|
5,188
|
2,892
|
2,778
|
5,670
|
2,986
|
2,752
|
5,738
|
2,798
|
2,766
|
5,564
|
2,919
|
2,768
|
5,689
|
2,918
|
4,781
|
5,753
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1,406
|
-
|
-
|
1,425
|
-
|
-
|
1,407
|
-
|
-
|
1,486
|
-
|
EBIT
1 |
-
|
-
|
-
|
569
|
356
|
-
|
627
|
644
|
1,271
|
689
|
589
|
1,278
|
655
|
588.2
|
1,269
|
675.1
|
1,970
|
1,346
|
-
|
Operating Margin
|
-
|
-
|
-
|
19.67%
|
12.81%
|
-
|
21%
|
23.4%
|
22.15%
|
24.62%
|
21.29%
|
22.97%
|
22.44%
|
21.25%
|
22.31%
|
23.14%
|
41.21%
|
23.4%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
172
|
-
|
-
|
434
|
-
|
550
|
269
|
-
|
-
|
Net income
1 |
343
|
-
|
-
|
-
|
-
|
-
|
-
|
298
|
-
|
365
|
-3
|
-
|
423
|
310.3
|
-
|
403.9
|
559.3
|
-
|
-
|
Net margin
|
13.06%
|
-
|
-
|
-
|
-
|
-
|
-
|
10.83%
|
-
|
13.05%
|
-0.11%
|
-
|
14.49%
|
11.21%
|
-
|
13.85%
|
11.7%
|
-
|
-
|
EPS
2 |
-
|
0.0189
|
-
|
0.0400
|
-
|
-
|
-
|
0.0320
|
-
|
0.0390
|
-
|
-
|
0.0460
|
0.0340
|
-
|
0.0445
|
0.0810
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.0180
|
-
|
-
|
0.0420
|
-
|
-
|
0.0220
|
-
|
0.0651
|
0.0470
|
-
|
Announcement Date
|
6/1/22
|
9/29/22
|
9/29/22
|
11/10/22
|
3/2/23
|
3/2/23
|
5/3/23
|
8/2/23
|
8/2/23
|
11/2/23
|
2/29/24
|
2/29/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
9,868
|
8,514
|
7,814
|
7,072
|
6,470
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.615
x
|
3.007
x
|
2.725
x
|
2.336
x
|
2.037
x
|
Free Cash Flow
1 |
1,759
|
1,866
|
1,480
|
1,700
|
1,833
|
ROE (net income / shareholders' equity)
|
4.97%
|
6.37%
|
9.76%
|
10.1%
|
10.3%
|
ROA (Net income/ Total Assets)
|
3.06%
|
3.05%
|
4.46%
|
4.72%
|
4.99%
|
Assets
1 |
34,633
|
34,435
|
32,804
|
35,741
|
36,363
|
Book Value Per Share
2 |
1.770
|
1.790
|
1.870
|
1.980
|
2.100
|
Cash Flow per Share
2 |
0.2200
|
0.2300
|
0.1700
|
0.2100
|
0.2400
|
Capex
1 |
304
|
234
|
338
|
342
|
368
|
Capex / Sales
|
2.8%
|
2.07%
|
2.95%
|
2.87%
|
2.95%
|
Announcement Date
|
3/2/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
3.29
GBP Average target price
3.62
GBP Spread / Average Target +10.03% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.29% | 38.18B | | +32.09% | 693B | | +29.39% | 584B | | -1.34% | 372B | | +20.34% | 332B | | +7.39% | 294B | | +14.25% | 239B | | -3.03% | 211B | | +10.02% | 210B | | +8.49% | 168B |
Other Pharmaceuticals
|